nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Afatinib in NSCLC harbouring EGFR mutations
|
de Marinis, Filippo |
|
2014 |
15 |
4 |
p. e148-e149 nvt p. |
artikel |
2 |
A risk-management approach for effective integration of biomarkers in clinical trials: perspectives of an NCI, NCRI, and EORTC working group
|
Hall, Jacqueline Anne |
|
2014 |
15 |
4 |
p. e184-e193 nvt p. |
artikel |
3 |
Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis
|
Höckel, Michael |
|
2014 |
15 |
4 |
p. 445-456 12 p. |
artikel |
4 |
Atypical Spitz tumours and sentinel lymph node biopsy: a systematic review
|
Lallas, Aimilios |
|
2014 |
15 |
4 |
p. e178-e183 nvt p. |
artikel |
5 |
Atypical Spitz tumours and sentinel lymph nodes
|
Duncan, Lyn McDivitt |
|
2014 |
15 |
4 |
p. 377-378 2 p. |
artikel |
6 |
Baby Bear
|
Weaver, Meaghann Shaw |
|
2014 |
15 |
4 |
p. 383-384 2 p. |
artikel |
7 |
Bevacizumab for advanced cervical cancer
|
Sharma, Sharan |
|
2014 |
15 |
4 |
p. e155- 1 p. |
artikel |
8 |
Biomarker for fibrolamellar hepatocellular carcinoma
|
Benmaamar, Ramla |
|
2014 |
15 |
4 |
p. e156- 1 p. |
artikel |
9 |
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial
|
Pignata, Sandro |
|
2014 |
15 |
4 |
p. 396-405 10 p. |
artikel |
10 |
Circulating tumour cells: telling the truth about metastasis
|
Cristofanilli, Massimo |
|
2014 |
15 |
4 |
p. 365-366 2 p. |
artikel |
11 |
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
|
Bidard, François-Clément |
|
2014 |
15 |
4 |
p. 406-414 9 p. |
artikel |
12 |
Community experience of vemurafenib for BRAF V600 melanoma
|
Hersey, Peter |
|
2014 |
15 |
4 |
p. 369-370 2 p. |
artikel |
13 |
Complications of prostate cancer treatment
|
Bece, Andrej |
|
2014 |
15 |
4 |
p. e149-e150 nvt p. |
artikel |
14 |
Complications of prostate cancer treatment
|
Chen, Ronald C |
|
2014 |
15 |
4 |
p. e150- 1 p. |
artikel |
15 |
Complications of prostate cancer treatment
|
Linton, Kate D |
|
2014 |
15 |
4 |
p. e150-e151 nvt p. |
artikel |
16 |
Complications of prostate cancer treatment
|
Halperin, Ross |
|
2014 |
15 |
4 |
p. e151-e152 nvt p. |
artikel |
17 |
Complications of prostate cancer treatment – Author's reply
|
Nam, Robert |
|
2014 |
15 |
4 |
p. e152-e153 nvt p. |
artikel |
18 |
Correction to Lancet Oncol 2013; 14: 1205
|
|
|
2014 |
15 |
4 |
p. e154- 1 p. |
artikel |
19 |
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
|
Judson, Ian |
|
2014 |
15 |
4 |
p. 415-423 9 p. |
artikel |
20 |
Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial
|
Goss, Paul E |
|
2014 |
15 |
4 |
p. 474-482 9 p. |
artikel |
21 |
Epigenetics, opium, and cancer
|
Mahmoodpoor, Ata |
|
2014 |
15 |
4 |
p. e153- 1 p. |
artikel |
22 |
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial
|
Dearnaley, David P |
|
2014 |
15 |
4 |
p. 464-473 10 p. |
artikel |
23 |
Fertility preservation and consent
|
The Lancet Oncology, |
|
2014 |
15 |
4 |
p. 361- 1 p. |
artikel |
24 |
Follicular lymphoma: watch and wait is watch and worry
|
Ansell, Stephen M |
|
2014 |
15 |
4 |
p. 368-369 2 p. |
artikel |
25 |
4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial
|
Hoskin, Peter J |
|
2014 |
15 |
4 |
p. 457-463 7 p. |
artikel |
26 |
Increase of thyroid cancer in children from Fukushima?
|
Mayor, Susan |
|
2014 |
15 |
4 |
p. e158- 1 p. |
artikel |
27 |
International Cancer Control Partnership
|
Sullivan, Richard |
|
2014 |
15 |
4 |
p. 385-386 2 p. |
artikel |
28 |
NICE guidance on pixantrone monotherapy for multiply relapsed or refractory aggressive non-Hodgkin lymphoma
|
Landells, Linda J |
|
2014 |
15 |
4 |
p. 381-382 2 p. |
artikel |
29 |
One step forward, two steps back
|
Benjamin, Robert S |
|
2014 |
15 |
4 |
p. 366-367 2 p. |
artikel |
30 |
Oophorectomy in women with BRCA1 or BRCA2 mutations
|
Burki, Talha Khan |
|
2014 |
15 |
4 |
p. e156- 1 p. |
artikel |
31 |
Palliative chemotherapy leads to more deaths away from home
|
Tanday, Sanjay |
|
2014 |
15 |
4 |
p. e157- 1 p. |
artikel |
32 |
Quality of life as a primary endpoint in ovarian cancer trials
|
Mahner, Sven |
|
2014 |
15 |
4 |
p. 363-364 2 p. |
artikel |
33 |
Radiotherapy for indolent lymphomas: how much is enough?
|
Specht, Lena |
|
2014 |
15 |
4 |
p. 372-374 3 p. |
artikel |
34 |
Radiotherapy for renal-cell carcinoma
|
De Meerleer, Gert |
|
2014 |
15 |
4 |
p. e170-e177 nvt p. |
artikel |
35 |
Refining insight into cervical cancer progression
|
Sakuragi, Noriaki |
|
2014 |
15 |
4 |
p. 371-372 2 p. |
artikel |
36 |
Risk of CNS dissemination in extranodal lymphomas
|
Ferreri, Andrés J M |
|
2014 |
15 |
4 |
p. e159-e169 nvt p. |
artikel |
37 |
Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial
|
Ardeshna, Kirit M |
|
2014 |
15 |
4 |
p. 424-435 12 p. |
artikel |
38 |
Secondary thyroid tumours and mortality
|
Mayor, Susan |
|
2014 |
15 |
4 |
p. e155- 1 p. |
artikel |
39 |
SGO not soft on morcellation: risks and benefits must be weighed
|
Goff, Barbara A |
|
2014 |
15 |
4 |
p. e148- 1 p. |
artikel |
40 |
Stereotactic radiosurgery for more than four brain metastases
|
Lo, Simon S |
|
2014 |
15 |
4 |
p. 362-363 2 p. |
artikel |
41 |
Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study
|
Yamamoto, Masaaki |
|
2014 |
15 |
4 |
p. 387-395 9 p. |
artikel |
42 |
Surgery versus radiotherapy for prostate cancer
|
Burki, Talha Khan |
|
2014 |
15 |
4 |
p. e157- 1 p. |
artikel |
43 |
Survey finds barriers to palliative care at home
|
Burki, Talha Khan |
|
2014 |
15 |
4 |
p. e158- 1 p. |
artikel |
44 |
The bone substudy of MA.27: does bone make a difference?
|
Mathew, Aju |
|
2014 |
15 |
4 |
p. 375-377 3 p. |
artikel |
45 |
The Firefly Project
|
Penny, Helen |
|
2014 |
15 |
4 |
p. 384-385 2 p. |
artikel |
46 |
The need to expand global access to radiotherapy
|
Rodin, Danielle |
|
2014 |
15 |
4 |
p. 378-380 3 p. |
artikel |
47 |
The value of randomised trials for prostate cancer management
|
Loblaw, Andrew |
|
2014 |
15 |
4 |
p. 374-375 2 p. |
artikel |
48 |
Vemurafenib in patients with BRAF V600 mutated metastatic melanoma: an open-label, multicentre, safety study
|
Larkin, James |
|
2014 |
15 |
4 |
p. 436-444 9 p. |
artikel |
49 |
When Hope Whispers
|
Coburn, Cassie |
|
2014 |
15 |
4 |
p. 385- 1 p. |
artikel |